| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
1,898 |
1,384 |
$1.48M |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
1,414 |
715 |
$1.08M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,313 |
6,993 |
$656K |
| 92134 |
|
20,225 |
16,385 |
$565K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,417 |
5,473 |
$431K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
999 |
810 |
$79K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
900 |
769 |
$53K |
| J7999 |
Compounded drug, not otherwise classified |
814 |
737 |
$44K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
529 |
439 |
$40K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,220 |
957 |
$39K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
279 |
251 |
$28K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
46 |
45 |
$8K |
| 92250 |
|
180 |
148 |
$5K |
| 99243 |
|
12 |
12 |
$2K |
| 92235 |
|
19 |
14 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
13 |
12 |
$813.96 |